Gokgoz N - Search Results

1

Co-amplification and overexpression of CDK4, SAS and MDM2 occurs frequently in human parosteal osteosarcomas.

Wunder JS, Eppert K, Burrow SR, Gokgoz N, Bell RS, Andrulis IL. Wunder JS, et al. Among authors: gokgoz n. Oncogene. 1999 Jan 21;18(3):783-8. doi: 10.1038/sj.onc.1202346. Oncogene. 1999. PMID: 9989829

2

Expression of osteocalcin and its transcriptional regulators core-binding factor alpha 1 and MSX2 in osteoid-forming tumours.

Hopyan S, Gokgoz N, Bell RS, Andrulis IL, Alman BA, Wunder JS. Hopyan S, et al. Among authors: gokgoz n. J Orthop Res. 1999 Sep;17(5):633-8. doi: 10.1002/jor.1100170503. J Orthop Res. 1999. PMID: 10569470

3

Familial posterior fossa brain tumors of infancy secondary to germline mutation of the hSNF5 gene.

Taylor MD, Gokgoz N, Andrulis IL, Mainprize TG, Drake JM, Rutka JT. Taylor MD, et al. Among authors: gokgoz n. Am J Hum Genet. 2000 Apr;66(4):1403-6. doi: 10.1086/302833. Epub 2000 Mar 14. Am J Hum Genet. 2000. PMID: 10739763 Free PMC article.

4

p53 missense but not truncation mutations are associated with low levels of p21(CIP1/WAF1) mRNA expression in primary human sarcomas.

Mousses S, Gokgoz N, Wunder JS, Ozcelik H, Bull S, Bell RS, Andrulis IL. Mousses S, et al. Among authors: gokgoz n. Br J Cancer. 2001 Jun 15;84(12):1635-9. doi: 10.1054/bjoc.2001.1844. Br J Cancer. 2001. PMID: 11401317 Free PMC article.

5

Comparison of p53 mutations in patients with localized osteosarcoma and metastatic osteosarcoma.

Gokgoz N, Wunder JS, Mousses S, Eskandarian S, Bell RS, Andrulis IL. Gokgoz N, et al. Cancer. 2001 Oct 15;92(8):2181-9. doi: 10.1002/1097-0142(20011015)92:8<2181::aid-cncr1561>3.0.co;2-3. Cancer. 2001. PMID: 11596036

6

A mutant PTH/PTHrP type I receptor in enchondromatosis.

Hopyan S, Gokgoz N, Poon R, Gensure RC, Yu C, Cole WG, Bell RS, Jüppner H, Andrulis IL, Wunder JS, Alman BA. Hopyan S, et al. Among authors: gokgoz n. Nat Genet. 2002 Mar;30(3):306-10. doi: 10.1038/ng844. Epub 2002 Feb 19. Nat Genet. 2002. PMID: 11850620

7

Cloning and mutation analysis of ZFP276 as a candidate tumor suppressor in breast cancer.

Wong JCY, Gokgoz N, Alon N, Andrulis IL, Buchwald M. Wong JCY, et al. Among authors: gokgoz n. J Hum Genet. 2003;48(12):668-671. doi: 10.1007/s10038-003-0088-1. Epub 2003 Nov 7. J Hum Genet. 2003. PMID: 14605947

8

Epigenetic and genetic loss of Hic1 function accentuates the role of p53 in tumorigenesis.

Chen W, Cooper TK, Zahnow CA, Overholtzer M, Zhao Z, Ladanyi M, Karp JE, Gokgoz N, Wunder JS, Andrulis IL, Levine AJ, Mankowski JL, Baylin SB. Chen W, et al. Among authors: gokgoz n. Cancer Cell. 2004 Oct;6(4):387-98. doi: 10.1016/j.ccr.2004.08.030. Cancer Cell. 2004. PMID: 15488761 Free article.

9

LAF-4 is aberrantly expressed in human breast cancer.

To MD, Faseruk SA, Gokgoz N, Pinnaduwage D, Done SJ, Andrulis IL. To MD, et al. Among authors: gokgoz n. Int J Cancer. 2005 Jul 1;115(4):568-74. doi: 10.1002/ijc.20881. Int J Cancer. 2005. PMID: 15704140 Free article.

10

TP53 mutations and outcome in osteosarcoma: a prospective, multicenter study.

Wunder JS, Gokgoz N, Parkes R, Bull SB, Eskandarian S, Davis AM, Beauchamp CP, Conrad EU, Grimer RJ, Healey JH, Malkin D, Mangham DC, Rock MJ, Bell RS, Andrulis IL. Wunder JS, et al. Among authors: gokgoz n. J Clin Oncol. 2005 Mar 1;23(7):1483-90. doi: 10.1200/JCO.2005.04.074. J Clin Oncol. 2005. PMID: 15735124

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

46 results

Search Page